Podcast Episodes

Back to Search
Episode 499: APCCC 2026 - Radioligands
Episode 499: APCCC 2026 - Radioligands

This session from APCCC 2026 features expert Michael Morris discussing radioligand therapy, adaptive dosing, retreatment strategies, and the latest i…

5 months, 3 weeks ago

Short Long
View Episode
Episode 498: APCCC 2026 - mCRPC
Episode 498: APCCC 2026 - mCRPC

This APCCC podcast with Elena Castro features a detailed discussion on recent advances and ongoing debates in the treatment of castrate resistant pr…

5 months, 3 weeks ago

Short Long
View Episode
Episode 497: Reflections on the capivasertib ODAC
Episode 497: Reflections on the capivasertib ODAC

This podcast features a detailed discussion on the recent ODAC meeting, focusing on the evaluation of capivasertib, an AKT inhibitor in metastatic ho…

5 months, 3 weeks ago

Short Long
View Episode
Episode 496: APCCC 2026 - mHSPC Landscape
Episode 496: APCCC 2026 - mHSPC Landscape

Rob Jones joins us in Lugano at the APCCC Meeting to discuss areas of consensus and controversy in the mHSPC landscape including de-escalation strate…

5 months, 3 weeks ago

Short Long
View Episode
Episode 495: APCCC 2026 - Locally-advanced Prostate Cancer
Episode 495: APCCC 2026 - Locally-advanced Prostate Cancer

This episode with Piet Ost covers the latest insights from the APCCC conference in Lugano, focusing on locally advanced prostate cancer, biochemical …

5 months, 3 weeks ago

Short Long
View Episode
Episode 494: Duration of EVP in Multiple Urothelial Cancer Settings / Paper of the Month PPARG Inverse Agonist
Episode 494: Duration of EVP in Multiple Urothelial Cancer Settings / Paper of the Month PPARG Inverse Agonist

Matt Galsky joins the show to talk about duration of EVP in multiple bladder cancer settings. He also talks about his recent Nature Medicine manuscri…

5 months, 4 weeks ago

Short Long
View Episode
Episode 493: The Role of Chemotherapy in mHSPC
Episode 493: The Role of Chemotherapy in mHSPC

In the world of prostate cancer treatment, chemotherapy's role, especially in metastatic hormone-sensitive cases, remains a topic of much discussion …

6 months, 1 week ago

Short Long
View Episode
Episode 492: Novel Biomarkers and Targets in Germ Cell Tumors
Episode 492: Novel Biomarkers and Targets in Germ Cell Tumors

This podcast features Dr. Mike Glover from MDACC discussing recent advances in germ cell tumor research, focusing on novel biomarkers like microRNA a…

6 months, 2 weeks ago

Short Long
View Episode
Episode 491 Uromigos Japan: ASCO GU26速報!前立腺がん&腎がん
Episode 491 Uromigos Japan: ASCO GU26速報!前立腺がん&腎がん

前立腺がんはPEACE-3 final OSの結果について、腎がんはLITESPARK-011/022試験の解釈から実臨床への影響まで、現地での反応も含めて語り尽くします。

6 months, 3 weeks ago

Short Long
View Episode
Episode 490: Systemic Therapy Only in Patients wtih MIBC
Episode 490: Systemic Therapy Only in Patients wtih MIBC

Laura Bukavina, Tyler Stewart and Amanda Nizam join Brian and Tom to discuss and debate a new clinical trial exploring EVP in MIBC with omission of c…

6 months, 3 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us